What happened with MATV today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Mativ Holdings, Inc. supplies materials that customers use in products such as labels, packaging, air and water filters, and wound dressings. It combines polymers, fibers and resins, then coats or further processes them to meet requirements such as adhesion, filtration or protection. Customers pay for the resulting materials rather than for a standalone service.
Most revenue comes from Sustainable & Adhesive Solutions (SAS), which sells tapes, labels, liners, specialty paper, packaging and healthcare materials directly and through distributors. Filtration & Advanced Materials (FAM) supplies customers directly, mainly with filtration media and netting, alongside films used for applications such as vehicle paint protection and security glass.
No single customer dominates sales. Many products are customized, and most FAM products must pass lengthy customer qualification processes. Demand moves with customers’ end markets and economic cycles. Profitability also depends on pulp and resin costs and the ability to pass increases on to customers; some specialty resins have few suppliers and are difficult to replace. Environmental rules constrain manufacturing, while EU deforestation rules restrict sales of covered products linked to deforestation.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Mativ’s results hinge on specialty-material demand and input costs; Ahlstrom is another rival to watch, named alongside Mativ in Magnera’s competitive disclosure.
Magnera competes with Mativ for filtration and healthcare materials business and explicitly names Mativ as a rival. Its sales of air-filtration and healthcare materials to brands and private-label businesses offer a window into demand in markets Mativ also serves.
H.B. Fuller and Mativ share exposure to packaging, healthcare and construction demand: Fuller sells industrial adhesives to manufacturers, while Mativ sells adhesive-coated tapes, labels and healthcare materials. Fuller’s healthcare and building-adhesive sales are worth watching for demand in those overlapping markets.
Parker-Hannifin and Mativ share exposure to industrial and transportation filtration demand: Parker sells filtration systems and replacement filters, while Mativ sells the materials and components used for filtration.
Avient and Mativ both depend on manufacturers’ demand for specialized polymer materials: Avient blends purchased resins and additives into tailored polymers and composites, while Mativ turns polymers into performance films and substrates. Avient’s Specialty Engineered Materials sales offer a read on that shared demand, rather than on commodity-resin production.
Mativ Holdings, Inc. earningsThis company
Mativ's report will show whether its Filtration & Advanced Materials and Sustainable & Adhesive Solutions businesses are turning sales into more gross profit.
Read sales and gross profit together for both segments. If Filtration & Advanced Materials improves on both, its filtration media, films and other products are not only selling more but covering manufacturing costs better; flat or rising sales with falling gross profit would point to pressure from price, product mix or costs. Make the same comparison for Sustainable & Adhesive Solutions: rising sales with gross profit keeping pace would show better conversion of tape, label, packaging and healthcare revenue into profit; rising sales without higher gross profit would show that revenue is not yielding more profit. Together, the results show whether Mativ is turning demand into stronger gross profit.
Parker-Hannifin Corporation earningsPH
Parker Hannifin's report will show how sales and orders in industrial and transportation markets are shaping demand for filtration systems and replacement filters that use Mativ's materials and components.
Watch sales and orders in Parker Hannifin's industrial and transportation businesses. If both strengthen, demand for filtration systems and replacement filters has firmer support, which points to a steadier market for Mativ's filtration materials; if both weaken, demand downstream may be contracting and Mativ's filtration business faces more pressure. Parker Hannifin sells systems and filters; Mativ sells materials and components used in them. This report signals demand in a shared market, not Mativ's own sales.
Magnera Corporation earningsMAGN
Magnera's report will show how sales and profitability are faring in air-filtration and healthcare materials, markets where it competes directly with Mativ.
Read Magnera's sales and gross-profit performance together, and note what it says about demand for air-filtration and healthcare materials. If both hold or improve, the shared markets have support and a competitor is converting sales into profit; if both weaken, demand may be softer or competition harder to manage, putting pressure on Mativ in overlapping markets too. Magnera is a competitor, so its results are a market signal, not a measure of Mativ's own performance.
H.B. Fuller Company earningsFUL
H.B. Fuller's report will show what adhesive sales say about demand in packaging, healthcare and construction-related markets that also matter to Mativ's tape, packaging and healthcare businesses.
Watch H.B. Fuller's sales in healthcare and building-related businesses, along with what it says about packaging demand. Stronger sales in those markets suggest manufacturers and other customers are buying more adhesives, a supportive demand signal for Mativ's tapes, packaging and healthcare materials; weaker sales suggest those overlapping markets may be harder. Fuller sells industrial adhesives, while Mativ sells products such as adhesive-coated materials; they are not the same products. The report signals the direction of shared-market demand, not a substitute for Mativ's sales.
